SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : lcav
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W Shakespeare who wrote (815)5/28/1999 7:57:00 PM
From: BARRY ALLEN  Read Replies (1) of 942
 
If VISX loses its patent protection, then we will have lots of companies making low priced lasers. Eye doctors will buy the lasers outright and bypass companies like LCAV, LVCI, and OHSI. The industry will be crushed as will your and my investments. Eye surgery will be inexpensive and totally unprofitable from an investment prospective

Nothing wrong with healthy competition! Isn't that the American way? VISX first needs to lose their Royalty monopoly then the floodgates will open and companies like LCAV can offer a more reasonable price on the LASIK procedure. $500 less will motivate more patients to have this performed without negatively affecting their bottom line. Actually they can even further reduce their price and make it up on volume! The LASIK market is just in it's infancy, so there is plenty of room for competition. Again, volume will more than make up for any lower fees!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News